V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007189 | 240004487 | 1.65 | null | Palliative (P) | 2017-07-27 | 2017-08-22 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 240032782 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007190 | 240004487 | 1.81 | 100.4 | Adjuvant (A) | 2018-01-02 | 2018-01-05 | Carboplatin + Etoposide iv&po | N | N | 240032782 | CARBOPLATIN + ETOPOSIDE |
| 240007191 | 240004487 | 1.84 | 69.7 | Curative (C) | 2016-12-24 | 2017-01-07 | null | 99 | null | 240032782 | NOT MATCHED |
| 240007192 | 240004488 | null | 26.4 | null | 2013-02-19 | 2013-02-24 | Bendamustine + prednisolone | N | N | 240032790 | BENDAMUSTINE |
| 240007193 | 240004488 | 1.74 | 74.3 | Curative (C) | 2014-01-11 | 2014-01-23 | Trial Unspecified | Y | N | 240032790 | TRIAL |
| 240007194 | 240004488 | 1.72 | null | Disease modification (D) | 2015-07-16 | 2015-07-16 | Hydroxycarbamide | 02 | N | 240032790 | HYDROXYCARBAMIDE |
| 240007195 | 240004488 | 1.71 | 65 | Curative (C) | 2015-08-03 | 2015-09-21 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240032790 | CHLORAMBUCIL + RITUXIMAB |
| 240007196 | 240004488 | 1.61 | 67.4 | Palliative (P) | null | 2014-11-11 | CARBOPLATIN | N | N | 240032790 | CARBOPLATIN |
| 240007197 | 240004489 | null | 56.8 | null | 2016-04-30 | 2016-05-12 | Carboplatin AUC 2 - 5 | N | N | 240032821 | CARBOPLATIN |
| 240007198 | 240004489 | 1.85 | 85 | Neo-adjuvant (N) | 2014-06-27 | 2014-07-01 | CARBOPLATIN + ETOPOSIDE | N | N | 240032821 | CARBOPLATIN + ETOPOSIDE |
| 240007199 | 240004489 | null | 64.2 | Curative (C) | 2017-05-02 | 2017-05-02 | DA 3 + 10 | N | N | 240032821 | DA |
| 240007200 | 240004489 | 1.67 | 65.3 | Palliative (P) | null | 2014-12-01 | R Chlorambucil | N | N | 240032821 | CHLORAMBUCIL + RITUXIMAB |
| 240007201 | 240004490 | 1.62 | 58.8 | Palliative (P) | null | 2015-07-16 | Carboplatin AUC 6 - 10 | N | N | 240032828 | CARBOPLATIN |
| 240007202 | 240004491 | 1.58 | 63 | Palliative (P) | 2014-02-11 | 2014-02-11 | Hydroxycarbamide | N | N | 240032830 | HYDROXYCARBAMIDE |
| 240007203 | 240004491 | 1.64 | 84 | Curative (C) | 2015-01-23 | 2015-02-13 | null | 2 | N | 240032830 | NOT MATCHED |
| 240007204 | 240004492 | null | null | Palliative (P) | null | 2017-08-29 | CHLORAMBUCIL + RITUXIMAB | null | null | 240032833 | CHLORAMBUCIL + RITUXIMAB |
| 240007205 | 240004492 | 1.54 | 63.8 | Curative (C) | null | 2014-12-06 | null | 02 | null | 240032833 | NOT MATCHED |
| 240007206 | 240004493 | 1.61 | 68.9 | Palliative (P) | null | 2016-09-19 | CHLORAMBUCIL + RITUXIMAB | N | N | 240032842 | CHLORAMBUCIL + RITUXIMAB |
| 240007207 | 240004494 | 1.63 | 106.2 | Curative (C) | 2017-06-09 | 2017-08-04 | Chlorambucil | 02 | null | 240032843 | CHLORAMBUCIL |
| 240007208 | 240004494 | 1.58 | 54.4 | Neo-adjuvant (N) | 2016-07-02 | 2016-07-12 | INTERLACE TRIAL | 02 | N | 240032843 | INTERLACE TRIAL |
| 240007209 | 240004495 | 1.74 | 80.9 | Palliative (P) | null | 2017-10-31 | Chlorambucil | Y | N | 240032848 | CHLORAMBUCIL |
| 240007210 | 240010516 | 1.69 | 52.3 | Curative (C) | 2017-10-17 | 2017-11-01 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 240032850 | NOT MATCHED |
| 240007211 | 240010516 | 1.61 | 58 | Palliative (P) | 2013-04-15 | 2013-04-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | 240032850 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007212 | 240010516 | 1.61 | 46 | Palliative (P) | 2013-10-18 | 2013-10-24 | Carboplatin + Etoposide iv&po | null | null | 240032850 | CARBOPLATIN + ETOPOSIDE |
| 240007213 | 240010516 | 1.62 | null | Curative (C) | 2017-04-05 | 2017-04-14 | INTERLACE TRIAL | null | null | 240032850 | INTERLACE TRIAL |
| 240007214 | 240004496 | 1.59 | 0 | Curative (C) | null | 2017-08-31 | R Chlorambucil | Y | N | 240032862 | CHLORAMBUCIL + RITUXIMAB |
| 240007215 | 240004497 | 1.67 | 56 | null | null | 2016-09-17 | Bendamustine +/- Prednisolone | N | N | 240032865 | BENDAMUSTINE |
| 240007216 | 240004497 | 1.55 | 92.9 | Palliative (P) | 2017-08-30 | 2017-08-31 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 240032865 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007217 | 240004498 | 1.68 | null | Curative (C) | null | 2017-08-31 | Carboplatin AUC 2 - 5 | N | N | 240032870 | CARBOPLATIN |
| 240007218 | 240004499 | 1.61 | 83 | Palliative (P) | 2014-02-11 | 2014-02-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240032871 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007219 | 240004499 | null | null | Curative (C) | 2016-10-28 | 2016-11-17 | INTERLACE TRIAL | null | null | 240032871 | INTERLACE TRIAL |
| 240007220 | 240013488 | 1.73 | 94.2 | Curative (C) | 2016-07-03 | 2016-08-14 | CARBOPLATIN | N | N | 240032874 | CARBOPLATIN |
| 240007221 | 240013488 | 1.55 | 84.6 | Disease modification (D) | 2013-03-12 | 2013-03-12 | Chlorambucil + Pred + Rituximab | N | N | 240032874 | CHLORAMBUCIL + RITUXIMAB |
| 240007222 | 240013488 | 1.63 | 98.6 | Palliative (P) | 2015-12-14 | 2015-12-16 | SMILE | Y | N | 240032874 | TRIAL |
| 240007223 | 240013488 | 1.55 | 66.4 | Palliative (P) | 2015-04-21 | 2015-04-22 | Bevacizumab+Carbo+Pacliaxel | null | null | 240032874 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007224 | 240004500 | 1.58 | 68.8 | Disease modification (D) | 2013-11-27 | 2013-11-27 | Chlorambucil | N | N | 240032888 | CHLORAMBUCIL |
| 240007225 | 240004500 | 1.59 | 84.4 | Palliative (P) | null | 2013-07-19 | Carboplatin + Etoposide iv&po | Y | N | 240032888 | CARBOPLATIN + ETOPOSIDE |
| 240007226 | 240004500 | 1.72 | 78.3 | Palliative (P) | 2017-06-03 | 2017-06-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240032888 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007227 | 240004501 | 1.63 | null | null | 2017-06-11 | 2017-06-15 | Chlorambucil | N | N | 240032898 | CHLORAMBUCIL |
| 240007228 | 240004502 | 1.68 | 60.1 | Disease modification (D) | 2018-08-23 | 2018-09-08 | CHLORAMBUCIL + RITUXIMAB | null | N | 240032904 | CHLORAMBUCIL + RITUXIMAB |
| 240007229 | 240004503 | null | 50 | Curative (C) | 2016-04-08 | 2016-04-22 | Bevacizumab+Carbo+Pacliaxel | Y | N | 240032909 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007230 | 240004504 | 1.7 | 80.1 | Curative (C) | 2015-08-14 | 2015-08-29 | ALCL ALCL 99 Closed Pre Phase | 02 | N | 240032912 | NOT MATCHED |
| 240007231 | 240004505 | 1.62 | 53.9 | null | null | 2017-07-23 | Carboplatin + Etoposide iv&po | N | N | 240032915 | CARBOPLATIN + ETOPOSIDE |
| 240007232 | 240004506 | 1.65 | 56.8 | Palliative (P) | 2016-10-17 | 2016-10-17 | Carboplatin + Etoposide IV 3 day | N | N | 240032916 | CARBOPLATIN + ETOPOSIDE |
| 240007233 | 240004506 | 1.63 | 48 | Palliative (P) | 2015-06-18 | 2015-07-09 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240032916 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007234 | 240004506 | 1.65 | 92 | Curative (C) | 2014-07-25 | 2014-08-03 | INTERLACE TRIAL | N | N | 240032916 | INTERLACE TRIAL |
| 240007235 | 240004507 | 1.69 | 112.8 | Neo-adjuvant (N) | 2015-08-04 | 2015-08-04 | INTERLACE TRIAL | N | N | 240032923 | INTERLACE TRIAL |
| 240007236 | 240004508 | 1.86 | 66 | Disease modification (D) | 2017-09-21 | 2017-09-23 | Chlorambucil | 2 | Y | 240032924 | CHLORAMBUCIL |
| 240007237 | 240004508 | 1.71 | 88.7 | null | null | 2016-09-28 | Carboplatin + Etoposide iv&po | 02 | N | 240032924 | CARBOPLATIN + ETOPOSIDE |
| 240007238 | 240004509 | 1.67 | 78 | Not known (9) | 2013-08-16 | 2013-08-28 | Bendamustine + prednisolone | 2 | N | 240032929 | BENDAMUSTINE |